Search Count: 120
All
Selected
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2026-02-04 Classification: PROTEIN BINDING |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2026-02-04 Classification: PROTEIN BINDING Ligands: GOL |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2026-02-04 Classification: PROTEIN BINDING |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2026-02-04 Classification: PROTEIN BINDING |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.43 Å Release Date: 2026-02-04 Classification: PROTEIN BINDING Ligands: SO4 |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2026-02-04 Classification: PROTEIN BINDING |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2026-02-04 Classification: PROTEIN BINDING Ligands: EPE |
 |
Structure Of The Omicron Spike Rbd Bound By The Monobody S19382 (Local Refinement From Dimerized Spike Protein Ecds)
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-11-12 Classification: ANTIVIRAL PROTEIN/VIRAL PROTEIN |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2025-05-14 Classification: DE NOVO PROTEIN |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-05-14 Classification: DE NOVO PROTEIN Ligands: ETA, ACT, SCN, K |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2025-05-14 Classification: DE NOVO PROTEIN Ligands: SCN, K |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.91 Å Release Date: 2025-05-14 Classification: DE NOVO PROTEIN |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2025-05-14 Classification: DE NOVO PROTEIN Ligands: FMT, CA, TRS |
 |
The Cryo-Em Structure Of Recombinantly Expressed Hugdh In Complex With Udp-4-Keto-Xylose
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-03-05 Classification: OXIDOREDUCTASE/INHIBITOR Ligands: A1BCU |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-02-26 Classification: OXIDOREDUCTASE |